|
1
|
Ahmed R, Oborski MJ, Hwang M, Lieberman FS
and Mountz JM: Malignant gliomas: Current perspectives in
diagnosis, treatment, and early response assessment using advanced
quantitative imaging methods. Cancer Manag Res. 6:149–170.
2014.PubMed/NCBI
|
|
2
|
Stupp R, Mason WP, Van den Bent MJ, Weller
M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn
U, et al European Organisation for Research and Treatment of Cancer
Brain Tumor and Radiotherapy Groups, ; National Cancer Institute of
Canada Clinical Trials Group, : Radiotherapy plus concomitant and
adjuvant temozolomide for glioblastoma. N Engl J Med. 352:987–996.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fine HA: New strategies in glioblastoma:
Exploiting the new biology. Clin Cancer Res. 21:1984–1988. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ostrom QT, Bauchet L, Davis FG, Deltour I,
Fisher JL, Langer CE, Pekmezci M, Schwartzbaum JA, Turner MC, Walsh
KM, et al: The epidemiology of glioma in adults: A ‘state of the
science’ review. Neuro Oncol. 16:896–913. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang L, Ye X, Cai X, Su J, Ma R, Yin X,
Zhou X, Li H and Wang Z: Curcumin suppresses cell growth and
invasion and induces apoptosis by down-regulation of Skp2 pathway
in glioma cells. Oncotarget. 6:18027–18037. 2015.PubMed/NCBI
|
|
6
|
Walbert T and Chasteen K: Palliative and
supportive care for glioma patients. Cancer Treat Res. 163:171–184.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ma Z, Chu L, Liu H, Wang W, Li J, Yao W,
Yi J and Gao Y: Beneficial effects of paeoniflorin on non-alcoholic
fatty liver disease induced by high-fat diet in rats. Sci Rep.
7:448192017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang H, Qi Y, Yuan Y, Cai L, Xu H, Zhang
L, Su B and Nie H: Paeoniflorin ameliorates experimental autoimmune
encephalomyelitis via inhibition of dendritic cell function and
Th17 cell differentiation. Sci Rep. 7:418872017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen YF, Wu KJ and Wood WG: Paeonia
lactiflora extract attenuating cerebral ischemia and arterial
intimal hyperplasia is mediated by paeoniflorin via modulation of
VSMC migration and Ras/MEK/ERK signaling pathway. Evid Based
Complement Alternat Med. 2013:4824282013.PubMed/NCBI
|
|
10
|
Wang K, Zhu L, Zhu X, Zhang K, Huang B,
Zhang J, Zhang Y, Zhu L, Zhou B and Zhou F: Protective effect of
paeoniflorin on Aβ25–35-induced SH-SY5Y cell injury by
preventing mitochondrial dysfunction. Cell Mol Neurobiol.
34:227–234. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen T, Fu LX, Zhang LW, Yin B, Zhou PM,
Cao N and Lu YH: Paeoniflorin suppresses inflammatory response in
imiquimod-induced psoriasis-like mice and peripheral blood
mononuclear cells (PBMCs) from psoriasis patients. Can J Physiol
Pharmacol. 94:888–894. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li J, Huang S, Huang W, Wang W, Wen G, Gao
L, Fu X, Wang M, Liang W, Kwan HY, et al: Paeoniflorin ameliorates
interferon-alpha-induced neuroinflammation and depressive-like
behaviors in mice. Oncotarget. 8:8264–8282. 2017.PubMed/NCBI
|
|
13
|
Zhai T, Sun Y, Li H, Zhang J, Huo R, Li H,
Shen B and Li N: Unique immunomodulatory effect of paeoniflorin on
type I and II macrophages activities. J Pharmacol Sci. 130:143–150.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
He DY and Dai SM: Anti-inflammatory and
immunomodulatory effects of paeonia lactiflora pall., a traditional
Chinese herbal medicine. Front Pharmacol. 2:102011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang Q, Yuan Y, Cui J, Xiao T and Jiang
D: Paeoniflorin inhibits proliferation and invasion of breast
cancer cells through suppressing Notch-1 signaling pathway. Biomed
Pharmacother. 78:197–203. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang S and Liu W: Paeoniflorin inhibits
proliferation and promotes apoptosis of multiple myeloma cells via
its effects on microRNA-29b and matrix metalloproteinase-2. Mol Med
Rep. 14:2143–2149. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lu JT, He W, Song SS and Wei W:
Paeoniflorin inhibited the tumor invasion and metastasis in human
hepatocellular carcinoma cells. Bratisl Lek Listy. 115:427–433.
2014.PubMed/NCBI
|
|
18
|
Li W, Qi Z, Wei Z, Liu S, Wang P, Chen Y
and Zhao Y: Paeoniflorin inhibits proliferation and induces
apoptosis of human glioma cells via microRNA-16 upregulation and
matrix metalloproteinase-9 downregulation. Mol Med Rep.
12:2735–2740. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Nie XH, Ou-yang J, Xing Y, Li DY, Dong XY,
Liu RE and Xu RX: Paeoniflorin inhibits human glioma cells via
STAT3 degradation by the ubiquitin-proteasome pathway. Drug Des
Devel Ther. 9:5611–5622. 2015.PubMed/NCBI
|
|
20
|
Wang Z, Inuzuka H, Zhong J, Liu P, Sarkar
FH, Sun Y and Wei W: Identification of acetylation-dependent
regulatory mechanisms that govern the oncogenic functions of Skp2.
Oncotarget. 3:1294–1300. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang Z, Fukushima H, Inuzuka H, Wan L, Liu
P, Gao D, Sarkar FH and Wei W: Skp2 is a promising therapeutic
target in breast cancer. Front Oncol. 1:572011.
|
|
22
|
Seki R, Ohshima K and Okamura T:
Prognostic significance of Skp2 and p27kip in diffuse
large B cell lymphoma. Rinsho Ketsueki. 51:1741–1747. 2010.(In
Japanese). PubMed/NCBI
|
|
23
|
Frescas D and Pagano M: Deregulated
proteolysis by the F-box proteins SKP2 and beta-TrCP: Tipping the
scales of cancer. Nat Rev Cancer. 8:438–449. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bornstein G, Bloom J, Sitry-Shevah D,
Nakayama K, Pagano M and Hershko A: Role of the SCFSkp2 ubiquitin
ligase in the degradation of p21Cip1 in S phase. J Biol Chem.
278:25752–25757. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tsvetkov LM, Yeh KH, Lee SJ, Sun H and
Zhang H: p27Kip1 ubiquitination and degradation is
regulated by the SCFSkp2 complex through phosphorylated
Thr187 in p27. Curr Biol. 9:661–664. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kamura T, Hara T, Kotoshiba S, Yada M,
Ishida N, Imaki H, Hatakeyama S, Nakayama K and Nakayama KI:
Degradation of p57Kip2 mediated by SCFSkp2-dependent
ubiquitylation. Proc Natl Acad Sci USA. 100:pp. 10231–10236. 2003;
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Shin E, Kim SH, Jeong HY, Jang JJ and Lee
K: Nuclear expression of S-phase kinase-associated protein 2
predicts poor prognosis of hepatocellular carcinoma. APMIS.
120:349–357. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liu J, Wei XL, Huang WH, Chen CF, Bai JW
and Zhang GJ: Cytoplasmic Skp2 expression is associated with p-Akt1
and predicts poor prognosis in human breast carcinomas. PLoS One.
7:e526752012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen G, Cheng Y, Zhang Z, Martinka M and
Li G: Cytoplasmic Skp2 expression is increased in human melanoma
and correlated with patient survival. PLoS One. 6:e175782011.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Saigusa K, Hashimoto N, Tsuda H, Yokoi S,
Maruno M, Yoshimine T, Aoyagi M, Ohno K, Imoto I and Inazawa J:
Overexpressed Skp2 within 5p amplification detected by array-based
comparative genomic hybridization is associated with poor prognosis
of glioblastomas. Cancer Sci. 96:676–683. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chan CH, Li CF, Yang WL, Gao Y, Lee SW,
Feng Z, Huang HY, Tsai KK, Flores LG, Shao Y, et al: The Skp2-SCF
E3 ligase regulates Akt ubiquitination, glycolysis, herceptin
sensitivity, and tumorigenesis. Cell. 149:1098–1111. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lin HK, Chen Z, Wang G, Nardella C, Lee
SW, Chan CH, Yang WL, Wang J, Egia A, Nakayama KI, et al: Skp2
targeting suppresses tumorigenesis by Arf-p53-independent cellular
senescence. Nature. 464:374–379. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chan CH, Morrow JK, Li CF, Gao Y, Jin G,
Moten A, Stagg LJ, Ladbury JE, Cai Z, Xu D, et al: Pharmacological
inactivation of Skp2 SCF ubiquitin ligase restricts cancer stem
cell traits and cancer progression. Cell. 154:556–568. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lin HK, Wang G, Chen Z, Teruya-Feldstein
J, Liu Y, Chan CH, Yang WL, Erdjument-Bromage H, Nakayama KI, Nimer
S, et al: Phosphorylation-dependent regulation of cytosolic
localization and oncogenic function of Skp2 by Akt/PKB. Nat Cell
Biol. 11:420–432. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Schiffer D, Cavalla P, Fiano V, Ghimenti C
and Piva R: Inverse relationship between p27/Kip.1 and the F-box
protein Skp2 in human astrocytic gliomas by immunohistochemistry
and Western blot. Neurosci Lett. 328:125–128. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lee SH and McCormick F: Downregulation of
Skp2 and p27/Kip1 synergistically induces apoptosis in T98G
glioblastoma cells. J Mol Med (Berl). 83:296–307. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wang J, Huang Y, Guan Z, Zhang JL, Su HK,
Zhang W, Yue CF, Yan M, Guan S and Liu QQ: E3-ligase Skp2 predicts
poor prognosis and maintains cancer stem cell pool in
nasopharyngeal carcinoma. Oncotarget. 5:5591–5601. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Hung WC, Tseng WL, Shiea J and Chang HC:
Skp2 overexpression increases the expression of MMP-2 and MMP-9 and
invasion of lung cancer cells. Cancer Lett. 288:156–161. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Chan CH, Morrow JK, Zhang S and Lin HK:
Skp2: A dream target in the coming age of cancer therapy. Cell
Cycle. 13:679–680. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Nakayama K, Nagahama H, Minamishima YA,
Matsumoto M, Nakamichi I, Kitagawa K, Shirane M, Tsunematsu R,
Tsukiyama T, Ishida N, et al: Targeted disruption of Skp2 results
in accumulation of cyclin E and p27Kip1, polyploidy and
centrosome overduplication. EMBO J. 19:2069–2081. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Halfter H, Friedrich M, Resch A, Kullmann
M, Stögbauer F, Ringelstein EB and Hengst L: Oncostatin M induces
growth arrest by inhibition of Skp2, Cks1, and cyclin A expression
and induced p21 expression. Cancer Res. 66:6530–6539. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Singh SK, Hawkins C, Clarke ID, Squire JA,
Bayani J, Hide T, Henkelman RM, Cusimano MD and Dirks PB:
Identification of human brain tumour initiating cells. Nature.
432:396–401. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Galli R, Binda E, Orfanelli U, Cipelletti
B, Gritti A, De Vitis S, Fiocco R, Foroni C, Dimeco F and Vescovi
A: Isolation and characterization of tumorigenic, stem-like neural
precursors from human glioblastoma. Cancer Res. 64:7011–7021. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Chen J, Li Y, Yu TS, McKay RM, Burns DK,
Kernie SG and Parada LF: A restricted cell population propagates
glioblastoma growth after chemotherapy. Nature. 488:522–526. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Vosper J, Masuccio A, Kullmann M, Ploner
C, Geley S and Hengst L: Statin-induced depletion of geranylgeranyl
pyrophosphate inhibits cell proliferation by a novel pathway of
Skp2 degradation. Oncotarget. 6:2889–2902. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Wu L, Wang G, Wei J, Huang N, Zhang S,
Yang F, Li M, Zhou G and Wang L: Matrine derivative YF-18 inhibits
lung cancer cell proliferation and migration through
down-regulating Skp2. Oncotarget. 8:11729–11738. 2017.PubMed/NCBI
|
|
47
|
Liao YJ, Bai HY, Li ZH, Zou J, Chen JW,
Zheng F, Zhang JX, Mai SJ, Zeng MS, Sun HD, et al: Longikaurin A, a
natural ent-kaurane, induces G2/M phase arrest via downregulation
of Skp2 and apoptosis induction through ROS/JNK/c-Jun pathway in
hepatocellular carcinoma cells. Cell Death Dis. 5:e11372014.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Su J, Zhou X, Wang L, Yin X and Wang Z:
Curcumin inhibits cell growth and invasion and induces apoptosis
through down-regulation of Skp2 in pancreatic cancer cells. Am J
Cancer Res. 6:1949–1962. 2016.PubMed/NCBI
|
|
49
|
Yin X, Zhang Y, Su J, Hou Y, Wang L, Ye X,
Zhao Z, Zhou X, Li Y and Wang Z: Rottlerin exerts its anti-tumor
activity through inhibition of Skp2 in breast cancer cells.
Oncotarget. 7:66512–66524. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Su J, Wang L, Yin X, Zhao Z, Hou Y, Ye X,
Zhou X and Wang Z: Rottlerin exhibits anti-cancer effect through
inactivation of S phase kinase-associated protein 2 in pancreatic
cancer cells. Am J Cancer Res. 6:2178–2191. 2016.PubMed/NCBI
|
|
51
|
Gao D, Inuzuka H, Tseng A, Chin RY, Toker
A and Wei W: Phosphorylation by Akt1 promotes cytoplasmic
localization of Skp2 and impairs APCCdh1-mediated Skp2 destruction.
Nat Cell Biol. 11:397–408. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Huang H, Zhao W and Yang D: Stat3 induces
oncogenic Skp2 expression in human cervical carcinoma cells.
Biochem Biophys Res Commun. 418:186–190. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Wei Z, Jiang X, Qiao H, Zhai B, Zhang L,
Zhang Q, Wu Y, Jiang H and Sun X: STAT3 interacts with Skp2/p27/p21
pathway to regulate the motility and invasion of gastric cancer
cells. Cell Signal. 25:931–938. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Wang ST, Ho HJ, Lin JT, Shieh JJ and Wu
CY: Simvastatin-induced cell cycle arrest through inhibition of
STAT3/SKP2 axis and activation of AMPK to promote p27 and p21
accumulation in hepatocellular carcinoma cells. Cell Death Dis.
8:e26262017. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
He X, Xing D, Ding Y, Li Y, Xiang L, Wang
W and Du L: Determination of paeoniflorin in rat hippocampus by
high-performance liquid chromatography after intravenous
administration of Paeoniae Radix extract. J Chromatogr B Analyt
Technol Biomed Life Sci. 802:277–281. 2004. View Article : Google Scholar : PubMed/NCBI
|
